China’s CITIC Capital buys U.S. dental firm DDS LAB-Reuters

(Reuters) - CITIC Capital Partners, the private equity arm of CITIC Capital Holdings Ltd, said on Wednesday it had acquired U.S. dental company DDS LAB LLC on undisclosed terms.

DDS, established in 2005 and headquartered in Tampa, Florida, is a dental laboratory that sells custom dental products to dental service organisations, mid-size group practices and sole practitioner dentists across the United States.

“The U.S. dental lab sector is (worth) around $8 billion. Consolidation is widely expected given the current highly fragmented nature of the industry,” said Cindy Tam, a CITIC Capital executive, in an emailed response to Reuters questions.

Tam declined comment on the value of the acquisition but said Hong Kong-based CITIC Capital’s preferred deal size is between $30 million to $50 million.

Hong Kong-based CITIC Capital, which manages more than $2.6 billion in committed capital, is one of the most active China-based private equity firms buying assets overseas.

The firm has also been involved in two large consortium buyouts of U.S. listed China companies, the purchase for around $900 million of AsiaInfo-Linkage Inc and the $3.7 billion buyout of Focus Media Holding Ltd.

CITIC Capital partnered with California-based buyout firm Blue Sea Capital and DDS management to acquire the business.

Moelis & Co was financial advisor to DDS.

Related Posts

Leave a Reply

PEHUB Community

Join the 12503 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget